Research Unit for Cellular Immunotherapy, Research Center for Allergy and Immunology, The Institute of Physical and Chemical Research, RIKEN, Yokohama, Kanagawa 230-0045, Japan.
J Immunol. 2013 Jun 1;190(11):5609-19. doi: 10.4049/jimmunol.1300033. Epub 2013 Apr 29.
A key goal of vaccine immunotherapy is the generation of long-term memory CD8(+) T cells capable of mediating immune surveillance. We discovered a novel intercellular pathway governing the development of potent memory CD8(+) T cell responses against cell-associated Ags that is mediated through cross-presentation by XCR1(+) dendritic cells (DCs). Generation of CD8(+) memory T cells against tumor cells pulsed with an invariant NKT cell ligand depended on cross-talk between XCR1(+) and plasmacytoid DCs that was regulated by IFN-α/IFN-αR signals. IFN-α production by plasmacytoid DCs was stimulated by an OX40 signal from the invariant NKT cells, as well as an HMGB1 signal from the dying tumor cells. These findings reveal a previously unknown pathway of intercellular collaboration for the generation of tumor-specific CD8(+) memory T cells that can be exploited for strategic vaccination in the setting of tumor immunotherapy.
疫苗免疫治疗的一个关键目标是产生能够介导免疫监视的长效记忆 CD8(+)T 细胞。我们发现了一种新的细胞间途径,通过 XCR1(+)树突状细胞 (DC) 的交叉呈递来调节针对细胞相关抗原产生有效记忆 CD8(+)T 细胞反应,从而控制针对肿瘤细胞的 CD8(+)记忆 T 细胞的产生。依赖于 XCR1(+)和浆细胞样 DC 之间的串扰,通过不变自然杀伤 T 细胞配体脉冲的肿瘤细胞产生 CD8(+)记忆 T 细胞,该串扰受 IFN-α/IFN-αR 信号的调节。浆细胞样 DC 中 IFN-α 的产生受到不变自然杀伤 T 细胞 OX40 信号以及垂死肿瘤细胞中 HMGB1 信号的刺激。这些发现揭示了一种用于产生肿瘤特异性 CD8(+)记忆 T 细胞的细胞间协作的新途径,可用于肿瘤免疫治疗中疫苗接种的策略。